ADVANCED MALIGNANT TUMORS
Clinical trials for ADVANCED MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug SPGL008 enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug, SPGL008, in 96 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants receive the drug either through a vei…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 17, 2026 13:00 UTC
-
New hope for advanced cancers? early trial of JMT108 begins
Disease control Recruiting nowThis study is testing a new drug called JMT108 in people with advanced cancers that have not responded to or are not eligible for standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 436 adults will take pa…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated May 17, 2026 12:54 UTC
-
New Antibody-Drug TQB6411 enters human trials for advanced tumors
Disease control Recruiting nowThis early-phase study tests a new drug called TQB6411 in people with advanced cancers that have not responded to other treatments. The drug is designed to attach to specific targets on tumor cells and deliver a toxin to kill them. The main goals are to find a safe dose and check…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New cancer drug enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug called SSGJ-709 in 15 people with advanced cancers that have spread. The main goal is to check safety and find the right dose. Researchers will also look at how the drug moves through the body and whether it shrinks tumors.
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC